Colesevelam

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 375 publications

Drugs for hypercholesterolemia.

Drugs for hypercholesterolemia.

Journal: The Medical letter on drugs and therapeutics
Published: June 01, 2026

Comparison chart: Some non-statin lipid-lowering drugs.

Comparison chart: Some non-statin lipid-lowering drugs.

Journal: The Medical letter on drugs and therapeutics
Published: June 01, 2026

Bile Acid Detergency as Determinant of Liver Pathology in a Humanized Mouse Model of Progressive Familial Intrahepatic Cholestasis Type 3.

Bile Acid Detergency as Determinant of Liver Pathology in a Humanized Mouse Model of Progressive Familial Intrahepatic Cholestasis Type 3.

Journal: Cellular and molecular gastroenterology and hepatology
Published: October 17, 2025

Bile acid detergency as determinant of liver pathology in a humanized mouse model of progressive familial intrahepatic cholestasis type 3.

Bile acid detergency as determinant of liver pathology in a humanized mouse model of progressive familial intrahepatic cholestasis type 3.

Journal: Cellular and molecular gastroenterology and hepatology
Published: October 17, 2025

Bile Acid Binding Resins Improve Glucagon Receptor Agonist-Mediated Weight Loss in Diet-Induced Obese Mice.

Bile Acid Binding Resins Improve Glucagon Receptor Agonist-Mediated Weight Loss in Diet-Induced Obese Mice.

Journal: Obesity (Silver Spring, Md.)
Published: August 15, 2025

IMpact of therapY using coleSevelam treatment reducing bile acids in patients with fonTan cIrCulation (MYSTIC): Rationale and study design.

IMpact of therapY using coleSevelam treatment reducing bile acids in patients with fonTan cIrCulation (MYSTIC): Rationale and study design.

Journal: American heart journal
Published: July 02, 2025

Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid - cross-over trials in Ronneby, Sweden.

Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid - cross-over trials in Ronneby, Sweden.

Journal: Environment international
Published: June 15, 2025

Management of bile acid diarrhea in Italy: a survey.

Management of bile acid diarrhea in Italy: a survey.

Journal: Internal and emergency medicine
Published: April 17, 2025

Update of safety profile of bile acid sequestrants: A real-world pharmacovigilance study of the FDA adverse event reporting system.

Update of safety profile of bile acid sequestrants: A real-world pharmacovigilance study of the FDA adverse event reporting system.

Journal: PloS one
Published: March 30, 2025

Real-world family planning and pregnancy practices in women with homozygous familial hypercholesterolemia.

Real-world family planning and pregnancy practices in women with homozygous familial hypercholesterolemia.

Journal: Atherosclerosis
Published: February 23, 2025

Comparison chart: Safety of drugs for IBS in pregnancy and lactation.

Comparison chart: Safety of drugs for IBS in pregnancy and lactation.

Journal: The Medical letter on drugs and therapeutics
Published: February 06, 2025

Comparison chart: Some drugs for irritable bowel syndrome with diarrhea (IBS-D).

Comparison chart: Some drugs for irritable bowel syndrome with diarrhea (IBS-D).

Journal: The Medical letter on drugs and therapeutics
Published: February 06, 2025
Showing 1-12 of 375

Last Updated: 06/30/2026